標(biāo)題: Titlebook: Colorectal Cancer Liver Metastases; A Comprehensive Guid Mauro Monteiro Correia,Michael A. Choti,Go Wakabay Book 2020 Springer Nature Switz [打印本頁(yè)] 作者: 巡洋 時(shí)間: 2025-3-21 19:07
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases影響因子(影響力)
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases被引頻次
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases被引頻次學(xué)科排名
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases年度引用
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases年度引用學(xué)科排名
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases讀者反饋
書(shū)目名稱(chēng)Colorectal Cancer Liver Metastases讀者反饋學(xué)科排名
作者: mortuary 時(shí)間: 2025-3-21 22:20 作者: 使高興 時(shí)間: 2025-3-22 00:28 作者: 吞吞吐吐 時(shí)間: 2025-3-22 06:10 作者: NAUT 時(shí)間: 2025-3-22 10:11 作者: Texture 時(shí)間: 2025-3-22 14:16 作者: Texture 時(shí)間: 2025-3-22 18:25
Ping Zhou PhD,Feng Mei PhD,Hui Cai MDing liver resection, the most important variables were maximum size and number of CRLM, primary regional lymph node metastasis, and preoperative carcinoembryonic antigen level. In 2017, the eighth TNM cancer staging system of the Union for International Cancer Control and the American Joint Committe作者: 殺子女者 時(shí)間: 2025-3-22 22:08
Simulation and Serious Games for Educationat will influence their therapeutic approach..Our objective in this chapter is to discuss the prognostic characteristics of colorectal liver metastases considering the evolution of biological factors and multimodal treatments in addition to the classically studied factors..It was didactically divide作者: Mets552 時(shí)間: 2025-3-23 02:46 作者: 半球 時(shí)間: 2025-3-23 06:28
Barbara Flach,Maxim Makhinya,Orcun Gokselactors have been found to be independent predictors of survival. Resection margin status and width have been historically an important prognostic factor. Yet, more recent studies have challenged the oncologic impact of close or microscopically positive (R1) resection. This is particularly important 作者: burnish 時(shí)間: 2025-3-23 12:30
https://doi.org/10.1007/978-3-319-46630-9vival and cure in some cases. Besides the advances in imaging staging, identification of significant prognostic factors, development of new surgical techniques and strategies, more effective radiological interventional treatments, introduction of new drugs and drug regimens, and improvement of perio作者: Salivary-Gland 時(shí)間: 2025-3-23 14:50 作者: 使尷尬 時(shí)間: 2025-3-23 18:53 作者: 徹底明白 時(shí)間: 2025-3-24 02:15 作者: 肥料 時(shí)間: 2025-3-24 04:07
Transfer Learning in Optical Microscopylization (PVE) is to be performed before hepatectomy when the future liver remnant (FLR) is considered to be insufficient. Therefore, it becomes necessary to understand PVE indication and FLR evaluation. In this chapter, we summarize how to evaluate FLR from anatomical, physiological, and kinetic as作者: dictator 時(shí)間: 2025-3-24 08:20 作者: 等級(jí)的上升 時(shí)間: 2025-3-24 10:48 作者: 使混合 時(shí)間: 2025-3-24 15:57 作者: Yag-Capsulotomy 時(shí)間: 2025-3-24 22:49
Lecture Notes in Computer Science cure patients, but 80–90% of patients have unresectable liver disease. Conversion chemotherapy with doublet scheme associated or not with monoclonal antibodies or a triplet scheme has shown to increase response rates and R0 resection rates, although this strategy did not prove to increase overall s作者: adjacent 時(shí)間: 2025-3-25 00:15 作者: GULF 時(shí)間: 2025-3-25 03:47 作者: corn732 時(shí)間: 2025-3-25 08:36
978-3-030-25488-9Springer Nature Switzerland AG 2020作者: Agronomy 時(shí)間: 2025-3-25 12:20
Role of Imaging in the Management of Patients with Potentially Resectable CRLM,metastases (CRLM). Modalities such as ultrasound (US), multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are used for CRLM and hepatic assessment. This chapter will discuss the current role of these imaging modalities in the management of patients with potentially resectable CRLM.作者: HEAVY 時(shí)間: 2025-3-25 19:01
Conversion Chemotherapy for CRLM-Best Associations, and Does Conversion Translate into Longer Survi cure patients, but 80–90% of patients have unresectable liver disease. Conversion chemotherapy with doublet scheme associated or not with monoclonal antibodies or a triplet scheme has shown to increase response rates and R0 resection rates, although this strategy did not prove to increase overall survival rates in prospective clinical trials.作者: SUGAR 時(shí)間: 2025-3-25 21:44
Ping Zhou PhD,Zhuo Chen PhD,Kai Xie PhDmetastases (CRLM). Modalities such as ultrasound (US), multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are used for CRLM and hepatic assessment. This chapter will discuss the current role of these imaging modalities in the management of patients with potentially resectable CRLM.作者: inchoate 時(shí)間: 2025-3-26 04:00
Lecture Notes in Computer Science cure patients, but 80–90% of patients have unresectable liver disease. Conversion chemotherapy with doublet scheme associated or not with monoclonal antibodies or a triplet scheme has shown to increase response rates and R0 resection rates, although this strategy did not prove to increase overall survival rates in prospective clinical trials.作者: glamor 時(shí)間: 2025-3-26 07:34
Pierre L’Ecuyer,Nataly Giroux,Peter W. GlynnColorectal cancer liver metastases (CRLM) represent systemic disease and were considered incurable until the 1950s. Interdisciplinary treatment and prognosis have changed since then. This chapter provides a brief historical review of the evolution of surgery for resection of colorectal liver metastases.作者: 歡騰 時(shí)間: 2025-3-26 11:25 作者: Outmoded 時(shí)間: 2025-3-26 15:37
https://doi.org/10.1007/978-3-319-46630-9perative care, it has been the implementation of dedicated multidisciplinary teams (MDTs) that has made a difference toward better care. This chapter addresses the impact of MDT in the management of colorectal liver metastases.作者: cornucopia 時(shí)間: 2025-3-26 17:30
https://doi.org/10.1007/978-3-319-71637-4omarkers. In the near future, these biomarkers may be routinely used for guiding patient selection for surgical resection of CRLM, the choice and timing of systemic therapy, the sequencing of treatments, and individualizing patient-specific risk of recurrence and disease-related mortality.作者: 顯赫的人 時(shí)間: 2025-3-26 21:55 作者: 使成波狀 時(shí)間: 2025-3-27 03:58
https://doi.org/10.1007/978-3-030-32778-1ectable and the patient has an asymptomatic primary colon cancer, upfront surgical resection rather than initial chemotherapy may be offered for medically fit patients. In this chapter we discuss and summarise treatment algorithms for different presentations.作者: 凹槽 時(shí)間: 2025-3-27 08:21 作者: 圣人 時(shí)間: 2025-3-27 11:54
Molecular Biomarkers for the Management of Colorectal Cancer Liver Metastases,omarkers. In the near future, these biomarkers may be routinely used for guiding patient selection for surgical resection of CRLM, the choice and timing of systemic therapy, the sequencing of treatments, and individualizing patient-specific risk of recurrence and disease-related mortality.作者: 熒光 時(shí)間: 2025-3-27 17:16
Prognostic Factors of Colorectal Cancer Liver Metastasis,l to metastatic disease, and R0 resection), and related to extrahepatic metastatic disease..The evolution of studies on prognostic factors related to colorectal liver metastases is bringing more personalized information, individualizing these patients and their treatment.作者: 兩種語(yǔ)言 時(shí)間: 2025-3-27 18:07 作者: 能得到 時(shí)間: 2025-3-27 23:47 作者: 搜尋 時(shí)間: 2025-3-28 05:54 作者: PRO 時(shí)間: 2025-3-28 09:30 作者: 甜食 時(shí)間: 2025-3-28 14:30 作者: CORD 時(shí)間: 2025-3-28 16:31
Simulation and Synthesis in Medical Imaginggimen. There are no accepted predictive biomarkers to guide personalisation of therapy, and patient selection is based upon prognostic rather than predictive criteria. In this chapter we review the evidence for and against NACT, explore the role of biological therapies and provide a summary of current international guidelines.作者: institute 時(shí)間: 2025-3-28 19:33
The Biology of Colorectal Liver Metastases, epigenetic, transcriptional, and cellular interactions in the native and host microenvironments is in its initial stages. In this chapter, the stages of colorectal cancer liver metastasis are presented and highlighted by our current mechanistic understanding of metastasis biology.作者: generic 時(shí)間: 2025-3-29 00:47 作者: visual-cortex 時(shí)間: 2025-3-29 04:30
Neoadjuvant Chemotherapy for Resectable Colorectal Cancer Liver Metastases: Indications and Resultsgimen. There are no accepted predictive biomarkers to guide personalisation of therapy, and patient selection is based upon prognostic rather than predictive criteria. In this chapter we review the evidence for and against NACT, explore the role of biological therapies and provide a summary of current international guidelines.作者: 泛濫 時(shí)間: 2025-3-29 09:45
Multidisciplinary Team (MDT) and the Management of Colorectal Cancer Liver Metastases,perative care, it has been the implementation of dedicated multidisciplinary teams (MDTs) that has made a difference toward better care. This chapter addresses the impact of MDT in the management of colorectal liver metastases.作者: 煩憂 時(shí)間: 2025-3-29 14:30 作者: Interferons 時(shí)間: 2025-3-29 16:16
https://doi.org/10.1007/978-3-319-71637-4llow-up after the treatment of the primary. This diagnosis is based in clinical, laboratory, and radiological studies. This chapter will address the different circumstances of the diagnosis and the role of each of the present diagnostic tools.作者: decode 時(shí)間: 2025-3-29 20:37
Barbara Flach,Maxim Makhinya,Orcun Gokselor. Yet, more recent studies have challenged the oncologic impact of close or microscopically positive (R1) resection. This is particularly important to understand, as this is one factor which is potentially under the control of the surgeon.作者: BILE 時(shí)間: 2025-3-30 02:17
Simulation and Synthesis in Medical Imagingtes among patients with CRLM are warranted. Resectability of CRLM should be defined along three domains: from a medical standpoint, an oncologic standpoint, and finally a technical standpoint. Adherence to a stepwise protocol for preoperative evaluation of patients with CRLM is critical to ensure proper patient selection and to optimize outcomes.作者: Graduated 時(shí)間: 2025-3-30 07:40
Transfer Learning in Optical Microscopysary to understand PVE indication and FLR evaluation. In this chapter, we summarize how to evaluate FLR from anatomical, physiological, and kinetic aspects and we describe the effects and problems of PVE referring to previously published papers.作者: thalamus 時(shí)間: 2025-3-30 08:44
Diagnosis of Colorectal Liver Metastases,llow-up after the treatment of the primary. This diagnosis is based in clinical, laboratory, and radiological studies. This chapter will address the different circumstances of the diagnosis and the role of each of the present diagnostic tools.作者: Exterior 時(shí)間: 2025-3-30 12:22
What Is the Impact of Positive Margins in the Liver?,or. Yet, more recent studies have challenged the oncologic impact of close or microscopically positive (R1) resection. This is particularly important to understand, as this is one factor which is potentially under the control of the surgeon.作者: jettison 時(shí)間: 2025-3-30 16:56
Defining Resectability of Colorectal Cancer Liver Metastases: Technical and Oncologic Perspectives,tes among patients with CRLM are warranted. Resectability of CRLM should be defined along three domains: from a medical standpoint, an oncologic standpoint, and finally a technical standpoint. Adherence to a stepwise protocol for preoperative evaluation of patients with CRLM is critical to ensure proper patient selection and to optimize outcomes.作者: POWER 時(shí)間: 2025-3-30 23:11
Anatomical, Physiological, and Kinetic Evaluation of the Future Liver Remnant of CRLM After Portal sary to understand PVE indication and FLR evaluation. In this chapter, we summarize how to evaluate FLR from anatomical, physiological, and kinetic aspects and we describe the effects and problems of PVE referring to previously published papers.作者: 離開(kāi) 時(shí)間: 2025-3-31 03:43
The Biology of Colorectal Liver Metastases, the major cause of cancer-related mortality and continues to be a major challenge for clinicians and scientists. Developing earlier detection methods and more effective therapies requires understanding the complex mechanisms that drive colorectal cancer liver metastasis biology. However, due to the作者: Abduct 時(shí)間: 2025-3-31 06:15
Molecular Biomarkers for the Management of Colorectal Cancer Liver Metastases,es such as tumor size and focality, primary colon cancer nodal status, disease-free interval, and serum CEA level. Given the high risk of recurrence even after margin-negative resection for CRLM, these variables have been used to guide patient selection, treatment decisions, risk stratification, and作者: fluffy 時(shí)間: 2025-3-31 12:40 作者: Ballerina 時(shí)間: 2025-3-31 17:01
Role of Imaging in the Management of Patients with Potentially Resectable CRLM,metastases (CRLM). Modalities such as ultrasound (US), multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are used for CRLM and hepatic assessment. This chapter will discuss the current role of these imaging modalities in the management作者: obviate 時(shí)間: 2025-3-31 19:33
Staging Classifications of Colorectal Liver Metastases,ing liver resection, the most important variables were maximum size and number of CRLM, primary regional lymph node metastasis, and preoperative carcinoembryonic antigen level. In 2017, the eighth TNM cancer staging system of the Union for International Cancer Control and the American Joint Committe作者: 自愛(ài) 時(shí)間: 2025-3-31 22:41
Prognostic Factors of Colorectal Cancer Liver Metastasis,at will influence their therapeutic approach..Our objective in this chapter is to discuss the prognostic characteristics of colorectal liver metastases considering the evolution of biological factors and multimodal treatments in addition to the classically studied factors..It was didactically divide作者: 解開(kāi) 時(shí)間: 2025-4-1 04:02 作者: 百科全書(shū) 時(shí)間: 2025-4-1 08:50
What Is the Impact of Positive Margins in the Liver?,actors have been found to be independent predictors of survival. Resection margin status and width have been historically an important prognostic factor. Yet, more recent studies have challenged the oncologic impact of close or microscopically positive (R1) resection. This is particularly important 作者: 意外的成功 時(shí)間: 2025-4-1 12:53 作者: Mammal 時(shí)間: 2025-4-1 14:20 作者: SOW 時(shí)間: 2025-4-1 21:34
Algorithms for Patients with Colorectal Liver Metastasis, resectable disease should undergo surgery or be converted resectable with chemotherapy..The standard approach for synchronous metastasis comprises resection of the colorectal primary tumor, adjuvant chemotherapy, and then resection of the liver tumor. Other approaches are concomitant approach and r作者: 邊緣 時(shí)間: 2025-4-2 02:09
Treatment Options for Resectable Colorectal Liver Metastases in the Presence of Extrahepatic Diseas110(1):13–29, 1991; Fong et al. J Clin Oncol. 15(3):938–46, 1997). Nevertheless, widespread improvement in surgical morbidity and mortality, as well as improved efficacy of chemotherapeutic agents, has driven increased interest in surgical metastasectomy with the intent of improved survival and pote
